DayTwo

DayTwo stopped operating in August 2024

DayTwo is the only evidence-based solution in the market today that delivers a precision nutrition solution for metabolic disease (diabetes, prediabetes, clinical obesity, NASH) based on an individual gut microbiome-analysis and machine learning algorithms. DayTwo's program allows members to find a path to remission and prevention without the need to eliminate entire food groups such as carbohydrates. DayTwo meets our patients where they are today because it employs a precision nutrition solution based on a high resolution gut micriobiome analysis of each patient. This informs what foods and food combinations each patient can process while maintaining effective blood sugar control. DayTwo is truly personalized to each patient, not generalized or a “one-size-fits-all” approach like traditional dietary interventions (e.g. Keto, Atkins, Paleo, etc).